Anti-p185HER2 monoclonal antibodies: biological properties and potential for immunotherapy

Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival.

ESMO open·2025

Dose escalation in pediatric pelvic Ewing's Sarcoma: Insights from a national treatment planning exercise.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2025

Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrant.

Breast cancer research : BCR·2023

Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer.

Gynecologic oncology·2023

A 60 MeV proton beam-line dedicated to research and development programs.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2022